PedAM
Pediatric Disease Annotations & Medicines
| Disease | multiple sclerosis |
| Symptom | C0423716|neuropathic pain |
| Sentences | 14 |
| PubMedID- 22851976 | Central neuropathic pain in patients with multiple sclerosis (ms) is a common debilitating symptom, which is mostly treated with tricyclic antidepressants or antiepileptics 1. |
| PubMedID- 23288696 | Dysaesthetic pain is a common neuropathic pain in patients with multiple sclerosis. |
| PubMedID- 24347834 | Focused on neuropathic pain, associated with multiple sclerosis and guillain-barre syndrome, as well as with experimental autoimmune encephalomyelitis and experimental autoimmune neuritis, in animal models which enable investigations of behavioural changes, underlying mechanisms, and potential pharmacotherapeutic approaches for neuropathic pain, associated with these diseases. |
| PubMedID- 22629287 | Some placebo-controlled trials suggest significant analgesia in neuropathic pain due to multiple sclerosis and mixed neuropathy (e.g., post-herpetic, traumatic, vascular neuropathies, but others do not . |
| PubMedID- 25000215 | Each study included participants with a different type of neuropathic pain; central pain due to multiple sclerosis, pain following spinal cord injury, painful polyneuropathy, central post-stroke pain, postherpetic neuralgia, and post-mastectomy pain.none of the included studies provided first or second tier evidence. |
| PubMedID- 23837007 | It has recently been shown that anodal tdcs resulted in large positive effects on neuropathic pain due to multiple sclerosis, with long duration of the after-effect.23 it would be of interest to compare the effects of tdcs and trns in double-blind crossover studies. |
| PubMedID- 26103031 | Findings: use of marijuana for chronic pain, neuropathic pain, and spasticity due to multiple sclerosis is supported by high-quality evidence. |
| PubMedID- 20649467 | Central neuropathic pain occurs with multiple sclerosis, stroke, and spinal cord injury (sci). |
| PubMedID- 23180178 | A double-blind, randomized, placebo-controlled, parallel-group study of thc/cbd oromucosal spray in combination with the existing treatment regimen, in the relief of central neuropathic pain in patients with multiple sclerosis. |
| PubMedID- 23979527 | Pain: comorbidity of neuropathic pain and migraine in patients with multiple sclerosis. |
| PubMedID- 26480924 | Objective: we prospectively assessed the prevalence of neuropathic pain in patients with early multiple sclerosis and investigated the association of neuropathic pain with other clinical parameters. |
| PubMedID- 22301508 | In this case report, a 61-year-old woman with chronic central neuropathic pain due to multiple sclerosis is described. |
| PubMedID- 24133434 | For example, anodal m1 tdcs over five consecutive days resulted in a significant decrease of pain intensity after spinal cord injury (fregni et al., 2006a), and similar results were observed in chronic neuropathic pain due to multiple sclerosis (mori et al., 2010), chronic pelvic pain (fenton et al., 2009) and pain of various origin (antal et al., 2010; knotkova et al., 2013). |
| PubMedID- 26543389 | In addition, analgesic properties of cannabinoids are advanced in some cannabis sativa plant extracts for adjunctive treatment of neuropathic pain in patients with multiple sclerosis. |
Page: 1